136 related articles for article (PubMed ID: 12391263)
1. Haptenation of sulfonamide reactive metabolites to cellular proteins.
Manchanda T; Hess D; Dale L; Ferguson SG; Rieder MJ
Mol Pharmacol; 2002 Nov; 62(5):1011-26. PubMed ID: 12391263
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
3. Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells.
Roychowdhury S; Vyas PM; Svensson CK
Drug Metab Dispos; 2007 Apr; 35(4):676-81. PubMed ID: 17220235
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole.
Gruchalla RS; Pesenko RD; Do TT; Skiest DJ
J Allergy Clin Immunol; 1998 Mar; 101(3):371-8. PubMed ID: 9525454
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.
Bhaiya P; Roychowdhury S; Vyas PM; Doll MA; Hein DW; Svensson CK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):158-67. PubMed ID: 16603214
[TBL] [Abstract][Full Text] [Related]
6. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.
Naisbitt DJ; Hough SJ; Gill HJ; Pirmohamed M; Kitteringham NR; Park BK
Br J Pharmacol; 1999 Mar; 126(6):1393-407. PubMed ID: 10217534
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450.
Vyas PM; Roychowdhury S; Khan FD; Prisinzano TE; Lamba J; Schuetz EG; Blaisdell J; Goldstein JA; Munson KL; Hines RN; Svensson CK
J Pharmacol Exp Ther; 2006 Oct; 319(1):488-96. PubMed ID: 16857728
[TBL] [Abstract][Full Text] [Related]
8. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.
Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK
Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins.
Meekins CV; Sullivan TJ; Gruchalla RS
J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):1017-24. PubMed ID: 7798534
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.
Vyas PM; Roychowdhury S; Koukouritaki SB; Hines RN; Krueger SK; Williams DE; Nauseef WM; Svensson CK
J Pharmacol Exp Ther; 2006 Oct; 319(1):497-505. PubMed ID: 16857727
[TBL] [Abstract][Full Text] [Related]
13. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.
Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK
Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516
[TBL] [Abstract][Full Text] [Related]
14. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
[TBL] [Abstract][Full Text] [Related]
15. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
[TBL] [Abstract][Full Text] [Related]
16. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
[TBL] [Abstract][Full Text] [Related]
17. Time-course of toxicity of reactive sulfonamide metabolites.
Rieder MJ; Krause R; Bird IA
Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180
[TBL] [Abstract][Full Text] [Related]
18. Amoxicillin haptenates intracellular proteins that can be transported in exosomes to target cells.
Sánchez-Gómez FJ; González-Morena JM; Vida Y; Pérez-Inestrosa E; Blanca M; Torres MJ; Pérez-Sala D
Allergy; 2017 Mar; 72(3):385-396. PubMed ID: 27319758
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.
Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP
Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
